Read + Share
Amedeo Smart
Independent Medical Education
Elkeraie A, Elraggal M, AbouKhatwa M, Omar ME, et al. Safety of SGLT2 inhibitors in chronic kidney disease patients during Ramadan fasting: a prospective cohort study. J Nephrol 2025 Oct 24. doi: 10.1007/s40620-025-02438.PMID: 41136870
Email
LinkedIn
Privacy Policy